Intravenous Treatment Center NY is categorized under Family Practice Doctors in New York City, NY and active since 2009.
Intravenous Treatment Center NY was established in 2009, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 115 East 61st St, New York City, New York NY 10065 or by phoning (212) 753-8700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Intravenous Treatment Center NY |
| Address: | 115 East 61st St, New York City, New York 10065 |
| Phone Number: | (212) 753-8700 |
| Website Address: | djwolfmd.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Intravenous Treatment Center NY was started in 2009 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact for inquiries that concern Intravenous Treatment Center NY by calling the company number (212) 753-8700, as your correspondence is most welcome. Additionally, the physical location of the single location of Intravenous Treatment Center NY can be found at the coordinates 40.763955,-73.968243 as well as the street address 115 East 61st St in New York City, New York 10065.
For its online presence, you may visit Intravenous Treatment Center NY’s website at djwolfmd.com and engage with its social media outlets through on Twitter and on Facebook.